Dietmar Berger
Chief Tech/Sci/R&D Officer bei SANOFI
Profil
Dietmar P. Berger bekleidet die Position des Chief Medical Officer & Global Head-Development bei Sanofi. In seiner bisherigen Laufbahn hatte er die Position des Global Head-Research & Development bei Atara Biotherapeutics, Inc. inne, war Leiter des Klinischen Forschungszentrums am Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology bei Genentech, Inc. und Leiter des Klinischen Forschungszentrums am The Scripps Research Institute. Dr. Berger erhielt ein Diplom und einen Doktortitel von der Universität Freiburg.
Aktive Positionen von Dietmar Berger
Unternehmen | Position | Beginn |
---|---|---|
SANOFI | Chief Tech/Sci/R&D Officer | 01.01.2019 |
Ehemalige bekannte Positionen von Dietmar Berger
Unternehmen | Position | Ende |
---|---|---|
ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31.05.2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2018 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Corporate Officer/Principal | - |
Ausbildung von Dietmar Berger
University of Freiburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SANOFI | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Health Services |